{"id":"W2231307019","doi":"10.1200/jco.2006.24.18_suppl.7580","title":"A phase I trial of PS-341 and fludarabine for relapsed and refractory indolent non-Hodgkin’s lymphoma and chronic lymphocytic leukemia","year":2006,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Fludarabine; Mantle cell lymphoma; Chronic lymphocytic leukemia; Bendamustine; Follicular lymphoma; Internal medicine; Neutropenia; Gastroenterology; Macroglobulinemia; Oncology; Leukopenia; Lymphoma; Toxicity; Surgery; Leukemia; Chemotherapy; Multiple myeloma; Cyclophosphamide","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001496851,0.00124666,0.001469405,0.0004840151,0.0004198844,0.000734819,0.0009750865,0.001000767,0.004371401],"category_scores_gemma":[0.0006304841,0.0004878318,0.0008300087,0.00041115,0.000885428,0.0007399254,0.000400537,0.002520523,0.0008650005],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009649355,"about_ca_system_score_gemma":0.001495911,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00133478,"about_ca_topic_score_gemma":0.003354311,"domain_scores_codex":[0.9996337,0.000170885,0.00001780116,0.00005404841,0.00003354377,0.00009015618],"domain_scores_gemma":[0.9994708,0.00009077547,0.00005590803,0.00002974042,0.00002133324,0.0003315758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8141317,0.04942609,0.003941692,0.000856263,0.001168833,0.0004739216,0.0004365956,0.002235661,0.02091046,0.0006833489,0.004931487,0.1008039],"study_design_scores_gemma":[0.711286,0.2769366,0.006378988,0.00003150478,0.0002295052,0.0002416185,0.00005591813,0.0008547531,0.0009733356,0.0002012365,0.00279147,0.00001901536],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934275,0.001515787,0.0002592824,0.0004639319,0.0001259773,0.001668113,0.0004148014,0.00005922122,0.002065369],"genre_scores_gemma":[0.9908072,0.001203611,0.0009883887,0.000897712,0.000145983,0.001905234,0.001551598,0.00001266453,0.002487546],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004371401,"threshold_uncertainty_score":0.01462382,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0743556789712439,"score_gpt":0.4604413004812773,"score_spread":0.3860856215100334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}